===== Introduction / Scene Opening =====
▍ Real Consultation Scenario
A 35-year-old patient who completed an embryo transfer in Bishkek asked via a remote consultation platform on the 5th day after returning to China:
“I had IVF in Kyrgyzstan and came back. The local doctor told me to check blood HCG and do an ultrasound 14 days after the transfer. Which department should I go to? What materials do I need to bring? Will doctors in domestic tertiary hospitals recognize the treatment plan from Kyrgyzstan? Do I need to adjust the medication later?”
1. Selection of Institutions for Follow-up After Returning to China
Direct Answer: The first choice is a domestic tertiary hospital reproductive medicine center, the second choice is a tertiary hospital gynecology or obstetrics department, and the third choice is a local maternal and child health hospital. It is not recommended to complete key follow-up examinations at secondary hospitals without reproductive specialties or private clinics, because monitoring after overseas IVF requires judgment based on the stimulation protocol, transfer type, and medication history. General gynecologists may not be familiar with overseas medication plans.
When is it suitable to go to gynecology/obstetrics: Routine prenatal checkups after clinical pregnancy confirmation, NT scan, mid-trimester anomaly screening.
When is it not suitable to go to a non-specialist clinic: If abdominal pain, abnormal bleeding, slow HCG rise, suspected ectopic pregnancy or abnormal embryo development occur, you must go to a hospital with emergency ultrasound and reproductive endocrinology support.
1.1 Why Follow-up After Overseas IVF Becomes a Challenge
Reproductive centers in Kyrgyzstan provide patients with a detailed medication plan and follow-up schedule after embryo transfer. However, gynecologists in most domestic general hospitals are not familiar with the medication habits, luteal phase support protocols, and embryo grading systems of overseas reproductive centers. If patients cannot clearly explain their medication history or fail to bring complete medical records, an information gap occurs, making it difficult for domestic doctors to accurately determine what to check or adjust next.
Additionally, some test reports from Kyrgyzstan (e.g., hormone panel, semen analysis, chromosome karyotype) may use different reference ranges or units. Domestic doctors need time to verify. If patients do not translate or explain in advance, they may be asked to retake tests, resulting in wasted time and cost.
===== Actual Process =====2. Actual Process and Timeline for Follow-up After Returning to China
After returning from Kyrgyzstan, follow-up is divided into three key stages, each with different examination focuses and institutional choices.
| Stage | Time Point | Core Examinations | Recommended Institution |
|---|---|---|---|
| Early Embryo Monitoring | Day 10–14 after transfer | Blood HCG, Progesterone, Estradiol | Tertiary hospital reproductive center |
| Clinical Pregnancy Confirmation | Day 28–35 after transfer | Transvaginal ultrasound (gestational sac, yolk sac, fetal heartbeat) | Tertiary hospital reproductive center / Gynecology |
| Early Prenatal Transition | Weeks 6–12 of pregnancy | Ultrasound (NT), Thyroid function, Coagulation, Infection screening | Tertiary hospital obstetrics / Maternal and child health hospital |
Specific Process:
- Step 1: Before returning, obtain complete medical records from the Kyrgyzstan reproductive center (including stimulation protocol, egg retrieval record, embryo grading, transfer record, medication plan, remaining embryo status). It is recommended to obtain both electronic and paper versions with stamps, and prepare an English or Chinese translation in advance.
- Step 2: After returning, contact the target hospital's reproductive center immediately to confirm whether they accept overseas IVF patients for follow-up monitoring. Ask clearly what materials are needed and whether re-registration is required.
- Step 3: Complete blood tests and ultrasound according to the time points required by the Kyrgyzstan doctor, and send the results back to the Kyrgyzstan doctor (remote consultation). At the same time, let the domestic doctor evaluate whether medication adjustments are needed.
- Step 4: After clinical pregnancy is confirmed, gradually transition the main prenatal care to the domestic obstetrics department, but still keep a follow-up channel at the reproductive center for medication adjustments.
2.1 Differences in Handling Across Hospital Levels
Domestic hospitals vary significantly in their acceptance and process requirements for overseas IVF patients:
- National/Provincial Reproductive Medicine Centers: Most have an "Overseas IVF Follow-up Clinic" with dedicated doctors for overseas patients. They recognize Kyrgyzstan medical records and can directly continue the medication plan. Some hospitals require patients to undergo a basic hormone and ultrasound re-check at their facility before registration.
- Municipal Tertiary Hospital Gynecology Departments: They can usually order routine tests like HCG and progesterone, but doctors have limited knowledge of overseas medication plans (e.g., commonly used stimulation drugs and luteal support in Kyrgyzstan). Patients may need to provide medication instructions themselves, and the department is not responsible for adjusting the plan.
- Maternal and Child Health Hospitals: Suitable for routine prenatal checkups after pregnancy confirmation, but not recommended for key monitoring in the early post-transfer period due to the lack of reproductive endocrinology specialists and emergency ultrasound capabilities.
- Private Clinics/Outpatient Centers: Some high-end private clinics offer follow-up management services for overseas IVF, but costs are higher, and it is necessary to verify whether they have reproductive medicine qualifications.
3. Most Easily Overlooked Details
3.1 Four Most Common Pitfalls
- Pitfall 1: Going directly to a general gynecology department for HCG testing after returning. The gynecologist may not know the transfer date and medication plan, leading to misjudgment of whether HCG doubling is normal.
- Pitfall 2: Not contacting the domestic hospital in advance. Upon arrival, you find that re-registration and additional tests are needed, missing the optimal blood draw time.
- Pitfall 3: Showing the original Kyrgyzstan reports directly to the domestic doctor without translation or explanation. The doctor cannot understand the medication plan and embryo grading, making professional judgment impossible.
- Pitfall 4: Having both the domestic and Kyrgyzstan doctors adjust your plan simultaneously without communication, leading to overlapping or conflicting medications.
4. How Doctors View Overseas IVF Follow-up in China
From the perspective of domestic reproductive doctors, there are three core concerns regarding overseas IVF patients returning for follow-up: information completeness, medication standardization, and risk controllability.
- Information Completeness: Domestic doctors most want to see a complete treatment cycle record, including the type and total dose of stimulation drugs, egg retrieval date, embryo culture days, type of embryo transferred (cleavage/blastocyst), transfer date, and luteal phase support plan. Missing any item affects the assessment of the current pregnancy status.
- Medication Standardization: If the patient can provide a medication plan from the Kyrgyzstan doctor (preferably in English or Chinese), the domestic doctor can directly continue or fine-tune it. If the patient cannot clearly describe the medication, the doctor usually recommends starting a standard luteal support plan, but there is a risk of over-adjustment.
- Risk Controllability: The most common risks after overseas IVF are ectopic pregnancy, luteal phase insufficiency, and early miscarriage. Domestic doctors need to quickly assess these risks based on HCG doubling and ultrasound results. If the patient can provide the early HCG trend curve after transfer, it greatly aids decision-making.
5. Interpretation of Key Examination Indicators
After returning from transfer, the three core indicators are blood HCG, progesterone, and ultrasound. Below are the normal reference ranges at different time points (with transfer day as Day 0):
| Indicator | Examination Time | Reference Range | Notes |
|---|---|---|---|
| Blood HCG | Day 12–14 after transfer | >50 mIU/mL (blastocyst transfer) >30 mIU/mL (cleavage stage transfer) |
Repeat after 48 hours; normal doubling indicates good embryo viability |
| Progesterone | Day 14 after transfer | 15–30 ng/mL | Below 10 ng/mL requires adjustment of luteal phase support |
| Estradiol | Day 14 after transfer | 200–600 pg/mL | Used to assess ovarian luteal function and endometrial receptivity |
| Transvaginal Ultrasound | Day 28–35 after transfer | Visible gestational sac, yolk sac, fetal heartbeat | If no fetal heartbeat, repeat after 1 week for confirmation |
How to interpret: If HCG is low but doubles normally every other day, continue observation. If HCG does not rise or decreases, it may indicate biochemical pregnancy or miscarriage, requiring immediate medical attention. If progesterone is low, the domestic doctor may increase progesterone dosage or add oral progestins as needed.
===== Special Situations =====6. Special Situations
6.1 Abdominal Pain or Vaginal Bleeding
If persistent abdominal pain, unilateral lower abdominal stabbing pain, bright red vaginal bleeding, or large clots occur at any stage after transfer, go to the nearest tertiary hospital emergency department immediately and inform the emergency doctor: "Post-overseas IVF transfer, suspected ectopic pregnancy or threatened miscarriage." Emergency ultrasound and blood HCG are the primary diagnostic tools. Do not wait until the next day to go to the reproductive center.
6.2 Unsatisfactory HCG Doubling
If HCG is between 10–30 mIU/mL on day 14 after transfer and doubling is slow, domestic doctors usually recommend: ① Continue luteal support, repeat HCG and progesterone after 3 days; ② Perform transvaginal ultrasound to rule out ectopic pregnancy; ③ If HCG remains low and no gestational sac is seen on ultrasound, consider biochemical pregnancy. In this case, joint assessment by the Kyrgyzstan and domestic doctors is very important; maintain communication via remote consultation.
6.3 Transporting Remaining Embryos from Kyrgyzstan
If you plan to have another transfer in China later, you need to transport the remaining embryos from Kyrgyzstan to a qualified domestic reproductive center. The process includes: ① The receiving domestic hospital issues an "Embryo Transport Acceptance Letter"; ② The Kyrgyzstan hospital confirms the embryo cryopreservation status; ③ International dry ice transport (requires a professional reproductive logistics company); ④ The domestic hospital re-freezes the embryos upon receipt. The entire process takes 2–4 weeks and costs approximately 15,000–30,000 RMB. Note that not all domestic reproductive centers accept overseas transported embryos; confirm in advance.
===== Frequently Asked Questions =====7. Frequently Asked Questions
Q1: Can I use medical insurance for follow-up examinations after returning to China?
Routine tests like blood HCG, progesterone, and ultrasound are covered by medical insurance, but overseas IVF itself is not reimbursable. If the tests are ordered under "early pregnancy check" or "gynecological endocrine examination," some cities allow payment through the personal medical insurance account or pooled fund, depending on local policies.
Q2: Are test reports from Kyrgyzstan recognized in China?
Tertiary hospital reproductive centers generally recognize reports from正规 overseas hospitals, but they may require the original report copy or electronic version, and may need to re-check some key items (e.g., blood type, infectious disease screening) at their own facility. If the report is in Russian or Kyrgyz, it is recommended to have it translated into Chinese and notarized in advance.
Q3: Do I need to redo AMH or antral follicle count after returning?
If AMH and antral follicle count were done in Kyrgyzstan before stimulation and the report is within 6 months, domestic hospitals usually accept it. However, if ovarian function needs reassessment (e.g., considering another egg retrieval), the doctor may recommend repeating the tests.
Q4: Will the domestic doctor ask me to redo chromosome testing?
If the chromosome karyotype analysis report from Kyrgyzstan is issued by a正规 cytogenetics laboratory with sufficient resolution information, domestic doctors generally accept it. However, if the report is incomplete or the laboratory qualification cannot be confirmed, they may request a repeat test.
Q5: Can I take medication for diarrhea or a cold after transfer?
Yes, but inform the doctor that you are pregnant or suspected to be pregnant, and mention the luteal support medications you are using. Most cephalosporin antibiotics and acetaminophen can be used under medical guidance. Avoid medications like ibuprofen or aspirin that may affect pregnancy.
8. Follow-up Focus by Age Group
| Age Group | Follow-up Focus | Medication Adjustment Tendency |
|---|---|---|
| <35 years | HCG doubling, ultrasound confirmation of fetal heartbeat | Standard luteal support, generally no additional enhancement needed |
| 35–40 years | Progesterone level, thyroid function, blood glucose | May need enhanced luteal support, monitor for hypothyroidism risk |
| >40 years | HCG doubling speed, progesterone maintenance, ectopic pregnancy screening | Usually requires intensified luteal support, and early review of embryo chromosome screening results |
Follow-up after overseas IVF is a medical transition process, not simply a matter of "getting a blood test." Choosing an inappropriate hospital, failing to bring complete materials, or adjusting medication on your own can lead to monitoring errors, medication mistakes, or even pregnancy loss. It is recommended to coordinate with the hospital 1–2 weeks in advance, rather than looking for a hospital at the last minute on the day of the test. For patients with abdominal pain, bleeding, or a history of miscarriage, prioritize hospitals with reproductive specialty emergency capabilities.
① After confirming your return date, immediately contact the reproductive center of a domestic tertiary hospital to clarify the registration process and required materials;
② Before leaving Kyrgyzstan, obtain complete medical records (paper + electronic) and translate key information;
③ On the second day after returning, visit the target hospital's reproductive center for a basic orientation, without waiting until day 14 after transfer;
④ Maintain remote contact with the Kyrgyzstan doctor at least until clinical pregnancy is confirmed (6–8 weeks of pregnancy);
⑤ Share the domestic doctor's contact information with the Kyrgyzstan doctor, and arrange a three-way remote consultation if necessary.
This article is compiled based on assisted reproductive clinical practice and patient follow-up experience, and is not a substitute for individual medical advice. Please follow the specific follow-up plan recommended by your attending physician.